Characterizing Advanced Parkinson's Disease: Romanian Subanalysis from the OBSERVE-PD Study
暂无分享,去创建一个
A. Fasano | B. Popescu | O. Bajenaru | D. Jianu | A. Dulamea | M. Simu | V. Constantin | Koray Onuk | J. Szász | M. Vasile | D. Popescu
[1] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[2] K. Orbán-Kis,et al. Levodopa-Carbidopa Intestinal Gel Infusion Therapy Discontinuation: A Ten-Year Retrospective Analysis of 204 Treated Patients , 2020, Neuropsychiatric disease and treatment.
[3] A. Antonini,et al. Efficacy, safety and patient’s quality of life of long-term treatment with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease in Romania: Results from GLORIA observational study , 2020 .
[4] Z. Pirtošek,et al. Update on the Management of Parkinson's Disease for General Neurologists , 2020, Parkinson's disease.
[5] K. Orbán-Kis,et al. Profile Of Patients With Advanced Parkinson’s disease Suitable For Device-Aided Therapies: Restrospective Data Of A Large Cohort Of Romanian Patients , 2019, Neuropsychiatric disease and treatment.
[6] H. Yehia. MANAGE-PD: A clinician-reported tool to identify patients with Parkinson's disease inadequately controlled on oral medications – results from vignette-based validation , 2019, Journal of the Neurological Sciences.
[7] V. Fung,et al. Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients , 2019, BMC Neurology.
[8] Yoshihiro Kokubo,et al. Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, The Lancet Neurology.
[9] A. Antonini,et al. Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease: a multi-country Delphi-panel approach , 2018, Current medical research and opinion.
[10] C. Sampaio,et al. International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease , 2018, Movement disorders : official journal of the Movement Disorder Society.
[11] E. Tolosa,et al. Validation of a simple screening tool for early diagnosis of advanced Parkinson’s disease in daily practice: the CDEPA questionnaire , 2018, npj Parkinson's Disease.
[12] Pablo Martinez-Martin,et al. Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed , 2017, Journal of Neural Transmission.
[13] D. Weiss,et al. Classification of advanced stages of Parkinson’s disease: translation into stratified treatments , 2017, Journal of Neural Transmission.
[14] E. Dietrichs,et al. Algorithms for the treatment of motor problems in Parkinson's disease , 2017, Acta neurologica Scandinavica.
[15] E. Tolosa,et al. Consensus on the Definition of Advanced Parkinson's Disease: A Neurologists-Based Delphi Study (CEPA Study) , 2017, Parkinson's disease.
[16] C. Popescu,et al. The effect of levodopa–carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson’s disease: a multicenter Romanian experience , 2015, Journal of Neural Transmission.
[17] E. Dietrichs,et al. Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program. , 2015, Parkinsonism & related disorders.
[18] G. Deuschl,et al. MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[19] I. Forgacs,et al. Perceptions of symptoms and expectations of advanced therapy for Parkinson’s disease: preliminary report of a Patient-Reported Outcome tool for Advanced Parkinson’s disease (PRO-APD) , 2014, Health and Quality of Life Outcomes.
[20] B. Bloem,et al. Moving from physician-centered care towards patient-centered care for Parkinson's disease patients. , 2013, Parkinsonism & related disorders.
[21] J. Kulisevsky,et al. Enfermedad de Parkinson avanzada. Características clínicas y tratamiento (parte I) , 2013 .
[22] P. Worth. When the going gets tough: how to select patients with Parkinson's disease for advanced therapies , 2013, Practical Neurology.
[23] G. Deuschl,et al. Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review , 2013, Journal of Neurology.
[24] M. McHugh. Interrater reliability: the kappa statistic , 2012, Biochemia medica.
[25] S. Pedersen,et al. Practical Guidance on How to Handle Levodopa/Carbidopa Intestinal Gel Therapy of Advanced PD in a Movement Disorder Clinic , 2012, The open neurology journal.
[26] A. Spottke,et al. Impact of complications and comorbidities on treatment costs and health-related quality of life of patients with Parkinson's disease , 2012, Journal of the Neurological Sciences.
[27] A. Cronin-Golomb,et al. Relation of Subjective Quality of Life to Motor Symptom Profile in Parkinson's Disease , 2011, Parkinson's disease.
[28] S. Varanese,et al. Treatment of Advanced Parkinson's Disease , 2011, Parkinson's disease.
[29] Marios Politis,et al. Parkinson's disease symptoms: The patient's perspective , 2010, Movement disorders : official journal of the Movement Disorder Society.
[30] C. Clarke,et al. Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease. , 2009, Parkinsonism & related disorders.
[31] J. Jankovic,et al. Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results , 2008, Movement disorders : official journal of the Movement Disorder Society.
[32] Robert A. Hauser,et al. Levodopa: Past, Present, and Future , 2008, European Neurology.
[33] M. Jahanshahi,et al. Quality of life in Parkinson's disease: The relative importance of the symptoms , 2008, Movement disorders : official journal of the Movement Disorder Society.
[34] M. van den Akker,et al. Coronary heart disease and cardiovascular risk factors among people aged 25–65 years, as seen in Romanian primary healthcare , 2008, The European journal of general practice.
[35] R. Fitzpatrick,et al. Cross-cultural evaluation of the short form 8-item Parkinson's Disease Questionnaire (PDQ-8): results from America, Canada, Japan, Italy and Spain. , 2007, Parkinsonism & related disorders.
[36] Paolo Barone,et al. International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study , 2006, Movement disorders : official journal of the Movement Disorder Society.
[37] H. Glick,et al. Preference-based quality-of-life in patients with Parkinson’s disease , 2002, Neurology.
[38] A Schrag,et al. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population , 2000, Movement disorders : official journal of the Movement Disorder Society.
[39] George Wright,et al. The Delphi technique as a forecasting tool: issues and analysis , 1999 .
[40] M. Hoehn,et al. Parkinsonism , 1998, Neurology.
[41] M. Stewart. Effective physician-patient communication and health outcomes: a review. , 1995, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[42] Murray Turoff,et al. The Delphi method : techniques and applications , 1976 .
[43] N. Dalkey,et al. An Experimental Application of the Delphi Method to the Use of Experts , 1963 .
[44] C. Redecker,et al. Advanced stages of PD: interventional therapies and related patient-centered care , 2015, Journal of Neural Transmission.
[45] Katunina Ea,et al. [Epidemiology of Parkinson's disease]. , 2013, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.
[46] W. Weiner. An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines. , 2002, Neurology.
[47] George Wright,et al. Expert Opinions in Forecasting: The Role of the Delphi Technique , 2001 .
[48] H Sackman,et al. Delphi Assessment: Expert Opinion, Forecasting, and Group Process , 1974 .
[49] Bernice B Brown,et al. DELPHI PROCESS: A METHODOLOGY USED FOR THE ELICITATION OF OPINIONS OF EXPERTS , 1968 .